High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$118K
$118,040
Total Sells (Filtered)
$15.9M
$15,919,383
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| DYN |
Dyne Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-04-01 | $106,751 | S | Form 4 |
|
DYN
P
Dyne Therapeutics, Inc.
Posner Brian S
• Director
Discretionary BuyΔOwn +14.8%
2026-03-30
$34,160
|
||||||
| DYN |
Dyne Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +14.8%
|
2026-03-30 | $34,160 | P | Form 4 |
| DYN |
Dyne Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-11 | $2,530,562Large | S | Form 4 |
|
DYN
P
Dyne Therapeutics, Inc.
Posner Brian S
• Director
Discretionary BuyΔOwn +17.4%
2026-03-11
$38,700
|
||||||
| DYN |
Dyne Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +17.4%
|
2026-03-11 | $38,700 | P | Form 4 |
| DYN |
Dyne Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-10 | $10,000,327MEGAx3 | S | Form 4 |
| DYN |
Dyne Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-09 | $3,148,987Large | S | Form 4 |
|
DYN
P
Dyne Therapeutics, Inc.
Posner Brian S
• Director
Discretionary BuyΔOwn +35.3%
2026-03-06
$45,180
|
||||||
| DYN |
Dyne Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +35.3%
|
2026-03-06 | $45,180 | P | Form 4 |
| DYN |
Dyne Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-05 | $40,707 | S | Form 4 |
|
DYN
S
Dyne Therapeutics, Inc.
Friedl-Naderer Johanna
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-05
$2,205
|
||||||
| DYN |
Dyne Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-05 | $2,205 | S | Form 4 |
|
DYN
S
Dyne Therapeutics, Inc.
Kerr Douglas
• Officer • Chief Medical Officer
Sell to Cover
2026-03-05
$13,470
|
||||||
| DYN |
Dyne Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-05 | $13,470 | S | Form 4 |
| DYN |
Dyne Therapeutics, Inc.
|
CEO
Sell to Cover
|
2025-12-05 | $55,157 | S | Form 4 |
|
DYN
S
Dyne Therapeutics, Inc.
Friedl-Naderer Johanna
• Officer • Chief Commercial Officer
Sell to Cover
2025-12-05
$2,984
|
||||||
| DYN |
Dyne Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2025-12-05 | $2,984 | S | Form 4 |
|
DYN
S
Dyne Therapeutics, Inc.
Kerr Douglas
• Officer • Chief Medical Officer
Sell to Cover
2025-12-05
$18,234
|
||||||
| DYN |
Dyne Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-12-05 | $18,234 | S | Form 4 |